glp 1 risk of cancer An important article from @americancancersociety about GLP-1 medications and risk. Lots to break down here! #glp1 #weightloss #cancer | Eleonora Teplinsky, MD Dr. - The GLP-1 cancer

Research shows GLP-1 users face a 49% higher risk of vitamin D deficiency compared to other diabetes medications

These funds are designed to pay out claims to those who developed mesothelioma or other asbestos-related diseases due to exposure

6 Results from a systematic review and meta-analysis study showed that following discontinuation of weight management medications: Patients are estimated to return to baseline weight within 1.7 years 1,** Results from that same study also highlighted that following discontinuation of weight management medications: Cardiometabolic benefits may be lost, with markers estimated to return to baseline within 1.4 years 1,** Ongoing obesity treatment is needed for maintaining weight loss and improvements in cardiometabolic markers 4 Addressing Discontinuation Starts With Understanding What May Influence Adherence and Persistence 5 Long-term adherence is shaped by multiple, interconnected factorsand ongoing research continues to explore how challenges may interact over time

These medications slow gastric emptying to help control blood glucose and appetite, but this delayed digestion can increase gas formation, including hydrogen sulfide

Tirzepatide's role in targeting adipose tissue macrophages to reduce obesity-related inflammation and improve insulin resistance